// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Procedural Safety and Intermediate Term Efficacy of Zotarolimus Eluting Resolute Integrity Stent in the Management of Native Very Long Segment Coronary Artery Lesion: A Prospective Observational Real World Study with 12-Month Follow-up

Soumya Patra - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Effect of AntiProliferative Drug Concentration on Short Term Outcomes in Patients Undergoing Second Generation Drug Eluting Stent Implantation

Tapan Ghose - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Examining the Potential Effects of Coronary Stent Malapposition: Insights from Optical Coherence Tomography (OCT) and Computational Fluid Dynamics

Umair Hayat - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

First Report on the Procedural Safety and 6-Month Outcome of Patients Treated with 48mm Everolimus Eluting Stent

Mohd Kamal Mohd Arshad - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Long-Term Evaluation of Safety and Efficacy of Biodegradable Polymer Coated Sirolimus-Eluting Indolimus Coronary Stent System

Rajasekhar Durgaprasad - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Comparison of Second- and First-Generation Drug Eluting Stent for Percutaneous Coronary Chronic Total Occlusion Intervention

Min Soo Cho - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Stents in Patients with Multi-Vessel Coronary Artery Disease

Cheol Hyun Lee - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Efficacy Analysis of Transcatheter Closure of Coronary Artery Fistulas in 70 Cases - Single Center Experience

Wang Qian - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Safety and Efficacy of Manual Aspiration Thrombectomy Combined with Transradial Coronary Intervention in the Patients with ST Segment Elevation Myocardial Infarction

Yukio Mizuguchi - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Intracoronary Thrombolysis in a Case of Refractory No Flow After Very Late Stent Thrombosis

Goutam Datta - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Heparin

A Confusing Treatment for a Patient with Acute Coronary Syndrome

Liang-Ting Chiang - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sodium bicarbonate

Very Late Stent Thrombosis of Left-Main Trunk

Jun Pu - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

TAXUS

Coronary Thrombosis During Complex PCI Using Step by Step Retrograde Approach for LAD#7 CTO

Shingo Hosogi - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Crofelemer

Longitudinal Stent Elongation from LA- to LMC- During Retraction of Entrapped Jailed Guidewire from Diagonal Side Branch

Praskas Chandra Mandal - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Recurrent Thrombosis with Prasugrel

Shintaro Umemoto - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prasugrel

Sub-acute Stent Thrombosis - A Nightmare Complication

Wenbin Zhang - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

eptifibatide

Acute Brachial Artery Thrombosis Associated with Heparin-induced Thrombocytopenia After Transradial Coronary Intervention

Yisik Kim - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Two Years Follow-up of a Case with Peri-stent Contrast Staining After Implanting 2 Types of Second-generation Drug-eluting Stents, Resulted in Coronary Thrombosis During Intravascular Ultrasound Procedure

Tetsuro Kataoka - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Nitroprusside sodium

Bleeding Complications After Resolve Acute Stent Thrombosis

Hotmauli Siahaan - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Streptase

Successful Treatment for Acute Thrombotic Occlusion in Superficial Femoral Artery Stent Using Angio Sculpt PTA Balloon

Hideaki Otsuji - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

cilostazol

Copyright © 2026. QuantiNova All rights reserved